Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Hereditary Angioedema - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Osteogenesis imperfecta (OI) - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
ANX005, Emerging Drug Insight and Market Forecast – 2032
... the ANX005 for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
Pegcetacoplan (APL-2), Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the Pegcetacoplan (APL-2) for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in ... Read More
-
Dystrophic Epidermolysis Bullosa - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the market trends of Dystrophic Epidermolysis Bullosa (DEB) in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Dystrophic Epidermolysis Bullosa (DEB) market report provides ... Read More
-
Gastrointestinal Stromal Tumor (GIST) - Market Insight, Epidemiology And Market Forecast - 2032
... as well as the GIST market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The GIST market report provides current treatment practices, emerging drugs, and market share ... Read More
-
Onychomycosis - Market Insight, Epidemiology And Market Forecast - 2032
... the market trends of onychomycosis in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), Japan and China. The onychomycosis market report provides current treatment practices, emerging drugs, market share of the individual ... Read More
-
Essential tremor - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Neurofibromatosis Type 2 - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology And Market Forecast - 2032
... Sclerosing Cholangitis (PSC), historical and forecasted epidemiology as well as the market trends in the United States, the EU-5 (Germany, Spain, Italy, France, and United Kingdom), Nordic countries (Sweden, Finland, Denmark, and Norway), and Japan. ... Read More
-
Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2022
... (Wet-AMD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
SLS-005 Emerging Drug Insight and Market Forecast – 2032
... the SLS-005 for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
CIMZIA (Certolizumab pegol) Drug Insight and Market Forecast – 2032
... A detailed picture of the CIMZIA (Certolizumab pegol) for Crohn’s disease (CD) in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is ... Read More
-
Krabbe Disease - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Reldesemtiv Emerging Drug Insight and Market Forecast – 2032
... the Reldesemtiv for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
Acute Respiratory Distress Syndrome (ARDS) - Market Insight, Epidemiology And Market Forecast - 2032
... historical and forecasted epidemiology as well as the Acute Respiratory Distress Syndrome market trends in the United States, the EU-5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The Acute Respiratory Distress Syndrome ... Read More
-
VIASKIN Peanut Emerging Drug Insight and Market Forecast – 2032
... picture of the VIASKIN Peanut for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report ... Read More
-
Genital Warts (Condyloma Acuminatum)-Market Insights, Epidemiology, and Market Forecast–2032
... the Genital Warts market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China. The Genital Warts market report provides current treatment practices, emerging drugs, and market share ... Read More
-
Critical Limb Ischemia - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Usher Syndrome - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Large Granular Lymphocytic Leukemia (LGLL)- Market Insights, Epidemiology, and Market Forecast-2032
... epidemiology as well as the LGLL market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The LGLL market report provides current treatment practices, emerging drugs, LGLL market share ... Read More
-
Chikungunya - Pipeline Insight, 2022
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Epidermolysis Bullosa - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Pancreatic Cancer - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Epidermolysis Bullosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Epidermolysis Bullosa (Dermatology) pipeline landscape. Epidermolysis bullosa (EB) is a group of inherited bullous disorders characterized by blister formation in response to mechanical trauma. Symptoms include blistering of skin, deformity ... Read More
Research Assistance
